Skip to main content

Refenesen Mucus Relief

NDC 10956-846 · Reese Pharmaceutical Co

Generic nameDextromethorphan Hydrobromide / Guaifenesin
Dosage formTABLET
RouteORAL
Active ingredient(s)DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN
Strength20; 400 mg/1; mg/1
Pharmacologic classDecreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
Marketing categoryOTC MONOGRAPH DRUG

Packages

10956-846-30 — 1 BOTTLE in 1 CARTON (10956-846-30) / 30 TABLET in 1 BOTTLE

10956-846-50 — 1 BOTTLE in 1 CARTON (10956-846-50) / 50 TABLET in 1 BOTTLE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0904-7441 — Dextromethorphan HBr, Guaifenesin, 0904-7512 — Guaifenesin and Dextromethorphan, 0904-7513 — Guaifenesin and Dextromethorphan, 0904-7531 — brompheniramine maleate, dextromethorphan hydrobromide, 0924-0142 — Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, 10135-789 — Guaifenesin, 10135-790 — Guaifenesin, 10202-740 — Dextromethorphan HBr, Guaifenesin, 10956-059 — Guaifenesin, 10956-845 — Guaifenesin, 11383-311 — Dextromethorphan HBr, Guaifenesin, 11523-0008 — chlorpheniramine maleate, dextromethorphan hydrochloride, 11523-0038 — Acetaminophen, Chlorpheniramine maleate, Dextromethorphan hydrobromide, 11523-0094 — Acetaminophen, Guaifenesin, 11523-4326 — Chlorpheniramine maleate and Dextromethorphan hydrobromide, 11523-4358 — Acetaminophen,Dextromethorphan hydrobromide, doxylamine succinate, 11673-114 — dextromethorphan polistirex, 11673-267 — Guaifenesin and Dextromethorphan HBr, 11673-287 — Acetaminophen, Dextromethorphan Hydrobromide, Doxylamine succinate, 11673-312 — Acetaminophen, Dextromethorphan Hydrobromide, and Doxylamine Succinate, +2508 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.